*|MC:SUBJECT|*
bioRN News Oktober 2025
Autumn Glow: Discover life - the bioRN Life Science Cluster Magazine and more news from our vibrant Life Science ecosystem

Dear *|FNAME|* *|LNAME|*,

We are excited to present the very first issue of life - the bioRN Life Science cluster magazine
This magazine offers plenty of reasons to take a closer look at our vibrant life science ecosystem - at the same time, it’s a statement for innovation and Biotech made in Germany. On twelve pages, 𝗹𝗶𝗳𝗲 brings together stories that demonstrate how collaboration drives progress - whether through the new Excellence Cluster SynthImmune, the Health+Life Science Alliance Mannheim Heidelberg or groundbreaking innovation platforms such as BioMed X Institute. We also look at how Inno Growth BW strengthens investment in life sciences and how companies like VERAXA Biotech are putting Heidelberg on the global map. Further highlights are provided by contributions from BIMOVIS on structural biology, Molecular Health on precision medicine through data-driven intelligence and CONCEPT Heidelberg about quality and compliance through professional training. Read the issue here

What else happened in October?
Festival of Biologics, 1-3 October in Basel: This year, bioRN was represented with a booth at the Festival of Biologics and organised a PRECISEU panel on the topic >> how the EU regulatory can support ATMP developers<<. We were particularly pleased to meet many members on site who had eagerly taken advantage of the free tickets we were able to provide. 
Nordic Life Science Days, 13-14 November, GothenburgThis year bioRN represented the Life Science ecosystem with the members KyooBe Tech, PEPperPRINT and FGK Clinical Research at the German Pavilion, organised by the BMBF. The Nordic life science community in fact radiates impressive energy - especially when it comes to pipeline strength, deal activity, and fundraising. Therefor we were able to establish new connections with the Nordic community and explored new opportunities for partnership and innovation. 

HR Breakfast: Empowering leaders in transformation: The bioRN HR Community met to  discuss how HR can support leaders in times of change and how to uncover six essential Future Skills. The event was organised in cooperation with COMMHA Consulting, more information here. At the bioRN MarCom Breakfast on 21. October Tabea Rauscher, Creative Lead at EMBL, shared the inspiring nine-year journey of shaping the “One EMBL” brand – turning a fragmented identity into a coherent, powerful whole. more information here
Eager to become part of the Community? Contact Stephanie Füller, sf@biorn.org
 
South Australian Delegation and Prof. Stefanie Dimmeler on pioneering RNA therapies for the heart at the bioRN Lounge, 28 October.
This edition of the bioRN Lounge offered a truly global perspective — starting with an inspiring South Australian delegation pre-event that highlighted international opportunities for drug development on the other side of the globe.
The Kesselhaus at Urban Kitchen was filled to capacity when Prof Stefanie Dimmeler, Director of the Institute for Cardiovascular Regeneration at Goethe-University Frankfurt, started.sharing groundbreaking insights on how non-coding RNAs (ncRNAs) may revolutionize treatments for cardiovascular diseases and cardiac ageing. Find more information here.

In November, you will once again have numerous opportunities to experience our vibrant Life Science Ecosystem:

meet bioRN in November:
1) BIO Europe: 03-05.11.Vienna: meet us at the German Pavilion, #C201-07
2) bioRN Webinar on <<research allowance<<, 13 November, zoom, more Information and registration: here
3) C-Level-Circle: 18. November, 6pm KLINKER Café Heidelberg: >>Future-Proof Biotech: Resilience and Sustainable Innovation in the Rhein-Neckar Region<<, get more information here
4) Last bioRN Lounge of the year: 25. November, Urban Kitchen Heidelberg featuring Prof. Dr. Eva Blasco, Professor at the Institute for Molecular Systems Engineering and Advanced Materials, register here 
5) SAVE THE DATE: General Member Assembly, 11. December 2025, 4pm at the Tankturm in Heidelberg
6) life - the biomedical convention, 4 February, 2026, Heidelberg Congress Center: The preliminary agenda is out and we are happy to introduce a great line up in the TRACK SYNTHETIC BIOLOGY with key-note speaker Prof. Dr. Kerstin Göpfrich, Heidelberg University; Prof. Dr. Hendrik Dietz, TUM, PD Dr. Dr. Lukas Bunse, University Hospital Mannheim & DKFZ and many more. Programm and registration is available on the website

Don´t miss further news from the network at the bioRN website.
Find out about new bioRN events here and get the latest news about funding and growth opportunities at 05 | Opportunities.

We wish you a wonderful start to November!

Kind regards,

Stephanie Füller 
PR Manager

bioRN Life Science Cluster 
LinkedIn
Twitter
Website
01 | Research Highlights & News
02 | New Members
03 | Event Spotlights
04 | Event Calendar & Discounts
05 | Opportunities
06 | Open Positions
01 | Research Highlights & News

AbbVie: US + EU Golden Ticket 2025 – Apply by November 7, 2025 [more]


BioMed X launches Women’s Health R&D Accelerator in Heidelberg [more]

Celonic Group and CARBOGEN AMCIS Announce Strategic Alliance to Deliver Fully Integrated ADC Development and Manufacturing Platform [more]

DKFZ:
  • Acidic tumor environment promotes survival and growth of cancer cells [more]
  • Transparent artificial intelligence improves assessment of prostate cancer aggressiveness [more]
  • No GPS in the head: How the brain flexibly switches between internal maps [more]

EMBL: New tool offers single-cell study of specific genetic variants [more]

Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB): NGS-based diagnostics for identifying sepsis pathogens wins EARTO Innovation Award [more]

GalaTek GmbH and a:head bio AG Announce Strategic Collaboration to Automate Human Brain Organoid Workflows [more]

GeneNovate: Call for Application 2025/2026 | Application Deadline: 09.11.2025 [more]

Heidelberg Pharma: 
  • Heidelberg Pharma Advances to Cohort 9 in Phase I/IIa Trial of Lead ATAC Candidate HDP-101 in Multiple Myeloma [more]
  • Heidelberg Pharma Significantly Reduces Operating Costs and Focuses on Lead ADC Candidate HDP-101 Due to Delayed Milestone Payment [more]

Heidelberg University: 
  • PHOENIX fördert Forschung: Pharmazie Wissenschaftspreis für Pharmazeutische Technologie verliehen [more]
  • Successful Placement in Times Higher Education Rankings [more]
  • Two Life Sciences Bridge Awards for Heidelberg researchers [more]
  • Chris Mcguigan Drug Discovery Award For Heidelberg Virologist Stephan Urban [more]
  • Cannabis extract for the medicinal treatment of chronic back pain [more]
Karlsruhe Institute of Technology (KIT)How Fibrosis Disrupts the Heart’s Electrical Signals [more] 

Max Planck Institute for Medical ResearchNo more problems with reflective surfaces [more] 

Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia [more]

SPT Labtech: 
  • Clean Tech Innovation Day & Solar TAP Industry Day: Advanced solutions are needed [more]
  • SPT Labtech and Agilent Introduce Automated Target Enrichment Protocols for Genomic Workflows [more]
VectorBuilder: 
  • VectorBuilder Redefines Plasmid Standards with miniVec [more]
  • VectorBuilder Wins Two IMAPAC Awards, Cementing Leadership in Gene Therapy and CDMO Innovation [more]
VERAXA Biotech and Secarna Pharmaceuticals Initiate Antibody Oligonucleotide Conjugate Alliance in Immunology [more] 

WMT AG receives financing with participation from L-Bank’s “InnoGrowth BW” program [more]

02 | New Members


More information about the new members and other bioRN members can be found here.
Fabulous Sciences accelerates antibody discovery with Fabulousᴬᴵ, a fully computational pipeline that delivers human monoclonal antibody sequences ready for preclinical work in 3–5 days.  Starting from a defined antigen or research question, our team works with you to perform in silico affinity maturation that mirrors natural immune evolution. Each candidate is screened for developability, manufacturability, IP landscape, and payload compatibility, while optimization steps improve affinity, thermal stability, and expression and minimize off-target binding. The result is a focused panel of lab-ready human antibodies that shortens experimental cycles and lowers costs for therapeutic and diagnostic projects.
Fusix Biotech is a preclinical stage TUM spin-out that is developing a revolutionary broad-acting immuneoncology platform to treat aggressive solid cancers.
Green Elephant Biotech develops and distributes innovative plant-based solutions for scalable adherent cell cultivation. The company provides both academic researchers and industry with sustainable, high-efficiency labware that enables process intensification and reduces environmental impact. A pioneer in the use of polylactic acid (PLA) for labware, Green Elephant Biotech offers scalable tools for cell expansion — including the CellScrew® system — to accelerate production of novel Cell and Gene Therapies, vaccines, and biologics. The company’s mission is to advance both human health and environmental sustainability in the biopharmaceutical industry.
Lira is a consulting firm specialized in securing EU innovation funding. With deep expertise in R&D grants and a strong commitment to excellence, Lira helps bring breakthrough technologies to life. By mastering funding programs and perfecting proposal strategies, the firm empowers innovators to access the resources needed to transform ideas into real-world success.
Synovo GmbH, based in Tübingen, is a drug discovery company providing pre-clinical services for biotech and pharma clients, alongside collaborative research with public and private partners. Its services span Medicinal Chemistry, in vivo Pharmacology, Histology, and in vitro Assays, focusing on highly translatable disease models. Internally, Synovo researches endosome and lysosome modulation in ageing and degenerative diseases, improving mRNA, ASO, and LNP-based agents. The company also explores interactions between cardiovascular, metabolic, autoimmune, and degenerative diseases, including the impact of Western diets on immune responses.

03 | Event Spotlights

04 | Event Calendar & Discounts

Bio-Europe 2025
November 03-05, 2025 - Vienna, Austria >>
15 % Discount on Tickets.

 
BIMOVIS Art-meets-Science Vernissage 2025
November 06, 2025 - Heidelberg  >>

 
Webinar: Successfully applying for research allowances – practical knowledge for biotech & life sciences
November 13, 2025 - Online >>

 
bioRN C-Level Circle “Future-Proof Biotech: Resilience and Sustainable Innovation in the Rhine-Neckar Region”
November 18, 2025 - Heidelberg >>

 
Register now: 2nd Edition of the PRECISEU PM School This November – Webinars
November 24-28, 2025 - Online >>

 
BioFit 2025
December 02-03, 2025 - Strasbourg, France >>
20 % Discount on Tickets. Regular Fee Tickets end on September 25th.

 
MedFit 2025
December 02-03, 2025 - Strasbourg, France >>
20 % Discount on Tickets. Regular Fee Tickets end on September 25th.

 
Workshop: Learn from Experts – Maximize the Potential of Your Cell-Based Assays!
March 04-05, 2026 - Walldorf, Germany >>
15 % Discount for Members.

 
SaxoCell Conference 2026
June 02-03, 2026 - Dresden, Germany >>
20 % Discount for Members.

 

05 | Opportunities

In this section we provide selected information on funding calls and events. On our  website the section startup support you will find a calendar with all opportunities 
Pitches & Prizes: Trinational HealthTech Days, 13-14 November Basel + online;  more 

Open Calls:  
  •  Reminder: The European Commission is seeking input on the Biotech Act, a new initiative to accelerate the market uptake of biotechnology while balancing innovation, safety, and ethics. Share your insights and experiences by 10 November 2025 to help shape a practical and effective law. Respond to the Consultation by 10 November here. Your voice matters, especially for the bioRN Life Science ecosystem in a Europe-wide context.
  • Online Info Day - EIC Work Programme 2026 - BMFTR Horizont Europa, 13. November 
    more.
  • Land plant neuen Innovationsgutschein „Mittelstand trifft Start-up“: Baden-Württemberg.de;  more.

Knowledge Transfer:  EU BiotechAct Public consultation: The Commission would like to hear your views. website

InternationalisationMarkterschließungsprojekt: Gesundheitswirtschaft / Medizintechnik -Bulgarien, Brasilien,Schweiz Ägypten/Jordanien, Italien  website

Closings: 
Lakestar closes a USD 265 Million Continuation Vehicle | Lakestar
Marlin Equity Partners Closes Latest Fund Oversubscribed at Hard Cap | News | Marlin Equity Partners


 

06 | Open Positions
 

EVI:

  • ​Bilanzbuchhalter (m/w/d), Heidelberg  [more]

IKTZ gGmbH:

  • Projektmanager für die Herstellung von ATMP-Produkten (m, f, d) [more]

VERAXA:

  • Research assistant / Biological-technical assistant – Immuno Oncology (m/f/d) [more]
  • Chemical scientific assistants, chemical technical assistants, CTAs(m/f/d) [more]
Tweet Tweet
Forward Forward
Share Share

Imprint


Copyright © *|CURRENT_YEAR|* *|LIST:COMPANY|*, All rights reserved.
*|IFNOT:ARCHIVE_PAGE|* *|LIST:DESCRIPTION|*

Responsible for the content:
Dr. Julia Schaft

Editor: Stephanie Füller

Our mailing address is:
*|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Commercial Register: Mannheim, HRB 704801
VAT ID: DE 2630 64 014

unsubscribe from this list    update subscription preferences 

*|IF:REWARDS|* *|HTML:REWARDS|* *|END:IF|*